Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 445 entries
Sorted by: Best Match Show Resources per page
Embryotoxic and teratogenic effects of norfloxacin in pregnant female albino rats.

Advances in pharmacological sciences

Aboubakr M, Elbadawy M, Soliman A, El-Hewaity M.
PMID: 24639869
Adv Pharmacol Sci. 2014;2014:924706. doi: 10.1155/2014/924706. Epub 2014 Feb 03.

This study was designed to investigate the possible developmental teratogenicity of norfloxacin in rats. Forty pregnant female rats were divided into four equal groups. Group A received norfloxacin in a dose of 500 mg/kg·b·wt/day orally from 6th to 15th...

Cite
Aboubakr M, Elbadawy M, Soliman A, et al. Embryotoxic and teratogenic effects of norfloxacin in pregnant female albino rats. Adv Pharmacol Sci. 2014;2014:924706doi: 10.1155/2014/924706.
Aboubakr, M., Elbadawy, M., Soliman, A., & El-Hewaity, M. (2014). Embryotoxic and teratogenic effects of norfloxacin in pregnant female albino rats. Advances in pharmacological sciences, 2014924706. https://doi.org/10.1155/2014/924706
Aboubakr, Mohamed, et al. "Embryotoxic and teratogenic effects of norfloxacin in pregnant female albino rats." Advances in pharmacological sciences vol. 2014 (2014): 924706. doi: https://doi.org/10.1155/2014/924706
Aboubakr M, Elbadawy M, Soliman A, El-Hewaity M. Embryotoxic and teratogenic effects of norfloxacin in pregnant female albino rats. Adv Pharmacol Sci. 2014;2014:924706. doi: 10.1155/2014/924706. Epub 2014 Feb 03. PMID: 24639869; PMCID: PMC3930024.
Copy Download .nbib Format: NLM
Quinazolinone azolyl ethanols: potential lead antimicrobial agents with dual action modes targeting methicillin-resistant Staphylococcus aureus DNA.

Future medicinal chemistry

Peng XM, Peng LP, Li S, Avula SR, Kannekanti VK, Zhang SL, Tam KY, Zhou CH.
PMID: 27668522
Future Med Chem. 2016 Oct;8(16):1927-1940. doi: 10.4155/fmc-2016-0002. Epub 2016 Sep 26.

AIM: Due to bacterial drug resistance, a new series of quinazolinone azolyl ethanols were synthesized and evaluated.RESULTS: In vitro antibacterial assay showed that triazolyl ethanol quinazolinone 3a was the most active compound, especially against methicillin-resistant Staphylococcus aureus (MRSA) with...

Cite
Peng XM, Peng LP, Li S, et al. Quinazolinone azolyl ethanols: potential lead antimicrobial agents with dual action modes targeting methicillin-resistant Staphylococcus aureus DNA. Future Med Chem. 2016;8(16):1927-1940doi: 10.4155/fmc-2016-0002.
Peng, X. M., Peng, L. P., Li, S., Avula, S. R., Kannekanti, V. K., Zhang, S. L., Tam, K. Y., & Zhou, C. H. (2016). Quinazolinone azolyl ethanols: potential lead antimicrobial agents with dual action modes targeting methicillin-resistant Staphylococcus aureus DNA. Future medicinal chemistry, 8(16), 1927-1940. https://doi.org/10.4155/fmc-2016-0002
Peng, Xin-Mei, et al. "Quinazolinone azolyl ethanols: potential lead antimicrobial agents with dual action modes targeting methicillin-resistant Staphylococcus aureus DNA." Future medicinal chemistry vol. 8,16 (2016): 1927-1940. doi: https://doi.org/10.4155/fmc-2016-0002
Peng XM, Peng LP, Li S, Avula SR, Kannekanti VK, Zhang SL, Tam KY, Zhou CH. Quinazolinone azolyl ethanols: potential lead antimicrobial agents with dual action modes targeting methicillin-resistant Staphylococcus aureus DNA. Future Med Chem. 2016 Oct;8(16):1927-1940. doi: 10.4155/fmc-2016-0002. Epub 2016 Sep 26. PMID: 27668522.
Copy Download .nbib Format: NLM
Synthesis, Characterization, and Antifungal Studies of Cr(III) Complex of Norfloxacin and Bipiridyl Ligand.

Bioinorganic chemistry and applications

Debnath A, Hussain F, Masram DT.
PMID: 25276111
Bioinorg Chem Appl. 2014;2014:457478. doi: 10.1155/2014/457478. Epub 2014 Sep 03.

A novel slightly distorted octahedral complex of Cr(III) of norfloxacin (Nor) with the formula [Cr(III)(Nor)(Bipy)Cl2]Cl·2CH3OH has been synthesized hydrothermally in the presence of a N-containing heterocyclic compound 2,2'-bipyridyl (Bipy). The complex was characterized with FT-IR, elemental analysis, UV-visible spectroscopy,...

Cite
Debnath A, Hussain F, Masram DT. Synthesis, Characterization, and Antifungal Studies of Cr(III) Complex of Norfloxacin and Bipiridyl Ligand. Bioinorg Chem Appl. 2014;2014:457478doi: 10.1155/2014/457478.
Debnath, A., Hussain, F., & Masram, D. T. (2014). Synthesis, Characterization, and Antifungal Studies of Cr(III) Complex of Norfloxacin and Bipiridyl Ligand. Bioinorganic chemistry and applications, 2014457478. https://doi.org/10.1155/2014/457478
Debnath, Anamika, et al. "Synthesis, Characterization, and Antifungal Studies of Cr(III) Complex of Norfloxacin and Bipiridyl Ligand." Bioinorganic chemistry and applications vol. 2014 (2014): 457478. doi: https://doi.org/10.1155/2014/457478
Debnath A, Hussain F, Masram DT. Synthesis, Characterization, and Antifungal Studies of Cr(III) Complex of Norfloxacin and Bipiridyl Ligand. Bioinorg Chem Appl. 2014;2014:457478. doi: 10.1155/2014/457478. Epub 2014 Sep 03. PMID: 25276111; PMCID: PMC4168151.
Copy Download .nbib Format: NLM
Urinary Tract Infection among Antiretroviral Therapy Users and Nonusers in Jimma University Specialized Hospital, Jimma, Ethiopia.

International journal of microbiology

Debalke S, Cheneke W, Tassew H, Awol M.
PMID: 24829582
Int J Microbiol. 2014;2014:968716. doi: 10.1155/2014/968716. Epub 2014 Apr 16.

Background. The introduction of antiretroviral therapy (ART) has dramatically reduced morbidity related with bacterial infection including urinary tract infection (UTI) among patients with HIV/AIDS. This study was carried out to determine the prevalence of UTI and identify common bacterial...

Cite
Debalke S, Cheneke W, Tassew H, et al. Urinary Tract Infection among Antiretroviral Therapy Users and Nonusers in Jimma University Specialized Hospital, Jimma, Ethiopia. Int J Microbiol. 2014;2014:968716doi: 10.1155/2014/968716.
Debalke, S., Cheneke, W., Tassew, H., & Awol, M. (2014). Urinary Tract Infection among Antiretroviral Therapy Users and Nonusers in Jimma University Specialized Hospital, Jimma, Ethiopia. International journal of microbiology, 2014968716. https://doi.org/10.1155/2014/968716
Debalke, Serkadis, et al. "Urinary Tract Infection among Antiretroviral Therapy Users and Nonusers in Jimma University Specialized Hospital, Jimma, Ethiopia." International journal of microbiology vol. 2014 (2014): 968716. doi: https://doi.org/10.1155/2014/968716
Debalke S, Cheneke W, Tassew H, Awol M. Urinary Tract Infection among Antiretroviral Therapy Users and Nonusers in Jimma University Specialized Hospital, Jimma, Ethiopia. Int J Microbiol. 2014;2014:968716. doi: 10.1155/2014/968716. Epub 2014 Apr 16. PMID: 24829582; PMCID: PMC4009233.
Copy Download .nbib Format: NLM
Combination Therapy of Sophoraflavanone B against MRSA: In Vitro Synergy Testing.

Evidence-based complementary and alternative medicine : eCAM

Mun SH, Kang OH, Joung DK, Kim SB, Seo YS, Choi JG, Lee YS, Cha SW, Ahn YS, Han SH, Kwon DY.
PMID: 24319486
Evid Based Complement Alternat Med. 2013;2013:823794. doi: 10.1155/2013/823794. Epub 2013 Nov 10.

Sophoraflavanone B (SPF-B), a known prenylated flavonoid, was isolated from the roots of Desmodium caudatum. The aim of this study was to determine the antimicrobial synergism of SPF-B combined with antibiotics against methicillin-resistant Staphylococcus aureus (MRSA). MRSA, a multidrug-resistant...

Cite
Mun SH, Kang OH, Joung DK, et al. Combination Therapy of Sophoraflavanone B against MRSA: In Vitro Synergy Testing. Evid Based Complement Alternat Med. 2013;2013:823794doi: 10.1155/2013/823794.
Mun, S. H., Kang, O. H., Joung, D. K., Kim, S. B., Seo, Y. S., Choi, J. G., Lee, Y. S., Cha, S. W., Ahn, Y. S., Han, S. H., & Kwon, D. Y. (2013). Combination Therapy of Sophoraflavanone B against MRSA: In Vitro Synergy Testing. Evidence-based complementary and alternative medicine : eCAM, 2013823794. https://doi.org/10.1155/2013/823794
Mun, Su-Hyun, et al. "Combination Therapy of Sophoraflavanone B against MRSA: In Vitro Synergy Testing." Evidence-based complementary and alternative medicine : eCAM vol. 2013 (2013): 823794. doi: https://doi.org/10.1155/2013/823794
Mun SH, Kang OH, Joung DK, Kim SB, Seo YS, Choi JG, Lee YS, Cha SW, Ahn YS, Han SH, Kwon DY. Combination Therapy of Sophoraflavanone B against MRSA: In Vitro Synergy Testing. Evid Based Complement Alternat Med. 2013;2013:823794. doi: 10.1155/2013/823794. Epub 2013 Nov 10. PMID: 24319486; PMCID: PMC3844210.
Copy Download .nbib Format: NLM
Microbial evaluation of Limnophila rugosa Roth. (Merr) leaf.

Ayu

Acharya R, Padiya RH, Patel ED, Harisha CR, Shukla VJ.
PMID: 25558169
Ayu. 2014 Apr;35(2):207-10. doi: 10.4103/0974-8520.146259.

BACKGROUND: Limphonia rugosa Roth. (Merr.), family-Scrophulariaceae is considered as a botanical source of classical Ayurvedic drug Bhringaraja by the traditional practitioners of Odisha and is being used for the management of various disorders.AIM: To study the antimicrobial activity of...

Cite
Acharya R, Padiya RH, Patel ED, et al. Microbial evaluation of Limnophila rugosa Roth. (Merr) leaf. Ayu. 2014;35(2):207-10doi: 10.4103/0974-8520.146259.
Acharya, R., Padiya, R. H., Patel, E. D., Harisha, C. R., & Shukla, V. J. (2014). Microbial evaluation of Limnophila rugosa Roth. (Merr) leaf. Ayu, 35(2), 207-10. https://doi.org/10.4103/0974-8520.146259
Acharya, Rabinarayan, et al. "Microbial evaluation of Limnophila rugosa Roth. (Merr) leaf." Ayu vol. 35,2 (2014): 207-10. doi: https://doi.org/10.4103/0974-8520.146259
Acharya R, Padiya RH, Patel ED, Harisha CR, Shukla VJ. Microbial evaluation of Limnophila rugosa Roth. (Merr) leaf. Ayu. 2014 Apr;35(2):207-10. doi: 10.4103/0974-8520.146259. PMID: 25558169; PMCID: PMC4279330.
Copy Download .nbib Format: NLM
Increasing antimicrobial resistance among uropathogens: Is fosfomycin the answer?.

Urology annals

Sultan A, Rizvi M, Khan F, Sami H, Shukla I, Khan HM.
PMID: 25657539
Urol Ann. 2015 Jan-Mar;7(1):26-30. doi: 10.4103/0974-7796.148585.

INTRODUCTION: Urinary tract infection (UTI) is one of the most common infectious diseases in clinical practice. The choice of antibiotics for the treatment of UTI is limited by the rising rates of antibiotic resistance. There is an urgent need...

Cite
Sultan A, Rizvi M, Khan F, et al. Increasing antimicrobial resistance among uropathogens: Is fosfomycin the answer?. Urol Ann. 2015;7(1):26-30doi: 10.4103/0974-7796.148585.
Sultan, A., Rizvi, M., Khan, F., Sami, H., Shukla, I., & Khan, H. M. (2015). Increasing antimicrobial resistance among uropathogens: Is fosfomycin the answer?. Urology annals, 7(1), 26-30. https://doi.org/10.4103/0974-7796.148585
Sultan, Asfia, et al. "Increasing antimicrobial resistance among uropathogens: Is fosfomycin the answer?." Urology annals vol. 7,1 (2015): 26-30. doi: https://doi.org/10.4103/0974-7796.148585
Sultan A, Rizvi M, Khan F, Sami H, Shukla I, Khan HM. Increasing antimicrobial resistance among uropathogens: Is fosfomycin the answer?. Urol Ann. 2015 Jan-Mar;7(1):26-30. doi: 10.4103/0974-7796.148585. PMID: 25657539; PMCID: PMC4310112.
Copy Download .nbib Format: NLM
Global Phenotypic Characterization of Effects of Fluoroquinolone Resistance Selection on the Metabolic Activities and Drug Susceptibilities of Clostridium perfringens Strains.

International journal of microbiology

Park M, Rafii F.
PMID: 25587280
Int J Microbiol. 2014;2014:456979. doi: 10.1155/2014/456979. Epub 2014 Dec 21.

Fluoroquinolone resistance affects toxin production of Clostridium perfringens strains differently. To investigate the effect of fluoroquinolone resistance selection on global changes in metabolic activities and drug susceptibilities, four C. perfringens strains and their norfloxacin-, ciprofloxacin-, and gatifloxacin-resistant mutants were...

Cite
Park M, Rafii F. Global Phenotypic Characterization of Effects of Fluoroquinolone Resistance Selection on the Metabolic Activities and Drug Susceptibilities of Clostridium perfringens Strains. Int J Microbiol. 2014;2014:456979doi: 10.1155/2014/456979.
Park, M., & Rafii, F. (2014). Global Phenotypic Characterization of Effects of Fluoroquinolone Resistance Selection on the Metabolic Activities and Drug Susceptibilities of Clostridium perfringens Strains. International journal of microbiology, 2014456979. https://doi.org/10.1155/2014/456979
Park, Miseon, and Rafii, Fatemeh. "Global Phenotypic Characterization of Effects of Fluoroquinolone Resistance Selection on the Metabolic Activities and Drug Susceptibilities of Clostridium perfringens Strains." International journal of microbiology vol. 2014 (2014): 456979. doi: https://doi.org/10.1155/2014/456979
Park M, Rafii F. Global Phenotypic Characterization of Effects of Fluoroquinolone Resistance Selection on the Metabolic Activities and Drug Susceptibilities of Clostridium perfringens Strains. Int J Microbiol. 2014;2014:456979. doi: 10.1155/2014/456979. Epub 2014 Dec 21. PMID: 25587280; PMCID: PMC4283427.
Copy Download .nbib Format: NLM
Typing and Antibiogram of Vibrio cholerae Isolates from a Tertiary Care Hospital in Pune: A 3 Year Study.

Journal of global infectious diseases

Palewar MS, Choure AC, Mudshingkar S, Dohe V, Kagal A, Bhardwaj R, Jaiswal A, Sarkar B.
PMID: 25722619
J Glob Infect Dis. 2015 Jan-Mar;7(1):35-6. doi: 10.4103/0974-777X.146375.

A retrospective analysis was done over a period of 3 years (January 2010- December 2012) in a tertiary care hospital, Pune, to note the changes in the prevalence and distribution of biotypes, serotypes, antibiotic susceptibility pattern and phage types...

Cite
Palewar MS, Choure AC, Mudshingkar S, et al. Typing and Antibiogram of Vibrio cholerae Isolates from a Tertiary Care Hospital in Pune: A 3 Year Study. J Glob Infect Dis. 2015;7(1):35-6doi: 10.4103/0974-777X.146375.
Palewar, M. S., Choure, A. C., Mudshingkar, S., Dohe, V., Kagal, A., Bhardwaj, R., Jaiswal, A., & Sarkar, B. (2015). Typing and Antibiogram of Vibrio cholerae Isolates from a Tertiary Care Hospital in Pune: A 3 Year Study. Journal of global infectious diseases, 7(1), 35-6. https://doi.org/10.4103/0974-777X.146375
Palewar, Meghna S, et al. "Typing and Antibiogram of Vibrio cholerae Isolates from a Tertiary Care Hospital in Pune: A 3 Year Study." Journal of global infectious diseases vol. 7,1 (2015): 35-6. doi: https://doi.org/10.4103/0974-777X.146375
Palewar MS, Choure AC, Mudshingkar S, Dohe V, Kagal A, Bhardwaj R, Jaiswal A, Sarkar B. Typing and Antibiogram of Vibrio cholerae Isolates from a Tertiary Care Hospital in Pune: A 3 Year Study. J Glob Infect Dis. 2015 Jan-Mar;7(1):35-6. doi: 10.4103/0974-777X.146375. PMID: 25722619; PMCID: PMC4338449.
Copy Download .nbib Format: NLM
Antibacterial Activity of Polyaniline Coated Silver Nanoparticles Synthesized from Piper Betle Leaves Extract.

Iranian journal of pharmaceutical research : IJPR

Mamun Or Rashida M, Shafiul Islam M, Azizul Haque M, Arifur Rahman M, Tanvir Hossain M, Abdul Hamid M.
PMID: 27642330
Iran J Pharm Res. 2016;15(2):591-7.

Plants or natural resources have been found to be a good alternative method for nanoparticles synthesis. In this study, polyaniline coated silver nanoparticles (AgNPs) synthesized from Piper betle leaves extract were investigated for their antibacterial activity. Silver nanoparticles were...

Cite
Mamun Or Rashida M, Shafiul Islam M, Azizul Haque M, et al. Antibacterial Activity of Polyaniline Coated Silver Nanoparticles Synthesized from Piper Betle Leaves Extract. Iran J Pharm Res. 2016;15(2):591-7
Mamun Or Rashida, M., Shafiul Islam, M., Azizul Haque, M., Arifur Rahman, M., Tanvir Hossain, M., & Abdul Hamid, M. (2016). Antibacterial Activity of Polyaniline Coated Silver Nanoparticles Synthesized from Piper Betle Leaves Extract. Iranian journal of pharmaceutical research : IJPR, 15(2), 591-7.
Mamun Or Rashida, Md, et al. "Antibacterial Activity of Polyaniline Coated Silver Nanoparticles Synthesized from Piper Betle Leaves Extract." Iranian journal of pharmaceutical research : IJPR vol. 15,2 (2016): 591-7.
Mamun Or Rashida M, Shafiul Islam M, Azizul Haque M, Arifur Rahman M, Tanvir Hossain M, Abdul Hamid M. Antibacterial Activity of Polyaniline Coated Silver Nanoparticles Synthesized from Piper Betle Leaves Extract. Iran J Pharm Res. 2016;15(2):591-7. PMID: 27642330; PMCID: PMC5018287.
Copy Download .nbib Format: NLM
[Epidemiological aspects of ciprofloxacin-resistant Escherichia coli in a general hospital].

Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia

Serrano FJ, Muñoz RM, Vidal SS, Morán FG, García CB, Aznar AB.
PMID: 10878537
Rev Esp Quimioter. 2000 Mar;13(1):44-50.

The susceptibility to ciprofloxacin of 7288 Escherichia coli clinical isolates from 5667 patients was determined over a 4-year period (1995-1998). Information about the patients' age, sex, specimen type, date, origin and susceptibility to Escherichia coli isolates was studied, and...

Cite
Serrano FJ, Muñoz RM, Vidal SS, et al. Aspectos epidemiológicos de la resistenciade Escherichia coli a ciprofloxacinoen un hospital general. [Epidemiological aspects of ciprofloxacin-resistant Escherichia coli in a general hospital]. Rev Esp Quimioter. 2000;13(1):44-50
Serrano, F. J., Muñoz, R. M., Vidal, S. S., Morán, F. G., García, C. B., & Aznar, A. B. (2000). Aspectos epidemiológicos de la resistenciade Escherichia coli a ciprofloxacinoen un hospital general. [Epidemiological aspects of ciprofloxacin-resistant Escherichia coli in a general hospital]. Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, 13(1), 44-50.
Serrano, et al. "Aspectos epidemiológicos de la resistenciade Escherichia coli a ciprofloxacinoen un hospital general." [Epidemiological aspects of ciprofloxacin-resistant Escherichia coli in a general hospital]. Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia vol. 13,1 (2000): 44-50.
Serrano FJ, Muñoz RM, Vidal SS, Morán FG, García CB, Aznar AB. Aspectos epidemiológicos de la resistenciade Escherichia coli a ciprofloxacinoen un hospital general. [Epidemiological aspects of ciprofloxacin-resistant Escherichia coli in a general hospital]. Rev Esp Quimioter. 2000 Mar;13(1):44-50. Spanish. PMID: 10878537.
Copy Download .nbib Format: NLM
Spontaneous Bacterial Peritonitis.

Current treatment options in gastroenterology

Hillebrand DJ.
PMID: 12408785
Curr Treat Options Gastroenterol. 2002 Dec;5(6):479-489. doi: 10.1007/s11938-002-0036-8.

Spontaneous bacterial peritonitis (SBP) is the prototypical ascitic fluid infection occurring in patients with advanced liver disease and ascites. The key to successful treatment of SBP is a knowledge of appropriate antibiotic regimens and an understanding of the setting...

Cite
Hillebrand DJ. Spontaneous Bacterial Peritonitis. Curr Treat Options Gastroenterol. 2002;5(6):479-489doi: 10.1007/s11938-002-0036-8.
Hillebrand, D. J. (2002). Spontaneous Bacterial Peritonitis. Current treatment options in gastroenterology, 5(6), 479-489. https://doi.org/10.1007/s11938-002-0036-8
Hillebrand, Donald J.. "Spontaneous Bacterial Peritonitis." Current treatment options in gastroenterology vol. 5,6 (2002): 479-489. doi: https://doi.org/10.1007/s11938-002-0036-8
Hillebrand DJ. Spontaneous Bacterial Peritonitis. Curr Treat Options Gastroenterol. 2002 Dec;5(6):479-489. doi: 10.1007/s11938-002-0036-8. PMID: 12408785.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 445 entries